Fundz
New|Fundz now works inside Claude2 min

Discover more near‑term opportunities with better event intelligence.

Fundz combines its own real-time funding and M&A intelligence with executive moves, hiring shifts and other company changes, weighs each signal against your ideal customer profile, and delivers a ranked daily shortlist with the context and decision maker to contact. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

Biodeal Pharmaceuticals acquires Biological E facility

PRIVATESep 30, 2026

Acquiring Company

Biodeal Pharmaceuticals

Acquired Company

Biological E

NalagarhIndiaBiotechnologyHealth CarepharmaceuticalsManufacturingBiotechnologyHealth Care

Description

Biodeal Pharmaceuticals has acquired a sterile injectable manufacturing facility from Biological E Limited in Paonta Sahib, India. This strategic acquisition expands Biodeal's capacity and capabilities in sterile injectables for global markets. The facility enhances Biodeal’s manufacturing footprint and regulatory credentials. The acquisition is part of Biological E's investment in its vaccine R&D campus in Telangana.

Company Information

Company

Biodeal Pharmaceuticals

Location

Nalagarh Road

Nalagarh, Himachal Pradesh, India

About

Biodeal Pharmaceuticals is focused on delivering innovative solutions in the healthcare and pharmaceuticals sector. With a commitment to excellence, the company aims to drive growth and enhance patient outcomes. Biodeal is dedicated to exploring new opportunities in a competitive global market.

Fundz sees it the moment Biodeal Pharmaceuticals makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Biodeal Pharmaceuticals's next move

Learn about Strategic plan

Frequently asked

Who acquired Biological E?

Biological E was acquired by Biodeal Pharmaceuticals, based in Nalagarh. The deal was reported on September 30, 2026. Biodeal Pharmaceuticals is focused on delivering innovative solutions in the healthcare and pharmaceuticals sector. With a commitment to excellence, the company aims to drive growth and enhance patient outcomes. Biodeal Pharmaceuticals is privately held and operates in Biotechnology.

When did Biodeal Pharmaceuticals acquire Biological E?

Biodeal Pharmaceuticals's acquisition of Biological E was reported on September 30, 2026. Biodeal Pharmaceuticals has acquired a sterile injectable manufacturing facility from Biological E Limited in Paonta Sahib, India. This strategic acquisition expands Biodeal's capacity and capabilities in sterile injectables for global markets. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Biological E do?

Biological E is a prominent Indian vaccine and pharmaceutical company focused on developing and manufacturing vaccines. They are known for their advanced manufacturing capabilities and commitment to public health. It is privately held, operating in Manufacturing, and is based in India.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.